Cubist Systematic Strategies’s Biotech Acquisition Company Class A Ordinary Shares BIOT Stock Holding History

Cubist Systematic Strategies’s Portfolio BIOT Stock Details BIOT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-165,854	Closed	-$1.68M	–	4795
2022 Q4	$1.68M	Buy	165,854 +50,528	+44%	+$506K	0.01%	2004
2022 Q3	$1.14M	Buy	115,326 +97,515	+547%	+$964K	0.01%	2516
2022 Q2	$176K	Buy	+17,811	New	+$175K	﹤0.01%	3764

Cubist Systematic Strategies's BIOT Position: Q1 2023 in Review

Cubist Systematic Strategies sold out of Biotech Acquisition Company Class A Ordinary Shares (BIOT) in Q1 2023, closing a stake of 165,854 shares — an estimated $1.68M sold.

Cubist Systematic Strategies first reported a position in BIOT in Q2 2022 and held it in 3 quarters. The position peaked at $1.68M in Q4 2022. 0 funds tracked by Wall St. Rank hold BIOT as of Q1 2023.

Cubist Systematic Strategies reported no remaining Biotech Acquisition Company Class A Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 165,854 Biotech Acquisition Company Class A Ordinary Shares shares in Q1 2023, an estimated $1.68M.
Cubist Systematic Strategies first reported a position in Biotech Acquisition Company Class A Ordinary Shares in Q2 2022 and held it in 3 quarters.
Cubist Systematic Strategies's Biotech Acquisition Company Class A Ordinary Shares position peaked at $1.68M in Q4 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Class A Ordinary Shares as of Q1 2023.

Based on Cubist Systematic Strategies's 13F filing for Q1 2023, filed 15 May 2023.